nodes	percent_of_prediction	percent_of_DWPC	metapath
Iron—Fluid overload—Carboplatin—esophageal cancer	0.0428	0.0428	CcSEcCtD
Iron—Infusion site pain—Capecitabine—esophageal cancer	0.0351	0.0351	CcSEcCtD
Iron—Extravasation—Carboplatin—esophageal cancer	0.0305	0.0305	CcSEcCtD
Iron—Fibrosis—Cisplatin—esophageal cancer	0.0273	0.0273	CcSEcCtD
Iron—Phlebitis—Carboplatin—esophageal cancer	0.0224	0.0224	CcSEcCtD
Iron—Fibrosis—Capecitabine—esophageal cancer	0.0201	0.0201	CcSEcCtD
Iron—Chromaturia—Capecitabine—esophageal cancer	0.0161	0.0161	CcSEcCtD
Iron—Shivering—Capecitabine—esophageal cancer	0.0154	0.0154	CcSEcCtD
Iron—Fibrosis—Methotrexate—esophageal cancer	0.015	0.015	CcSEcCtD
Iron—Generalised oedema—Cisplatin—esophageal cancer	0.0131	0.0131	CcSEcCtD
Iron—Fluid overload—Cisplatin—esophageal cancer	0.0126	0.0126	CcSEcCtD
Iron—Chest tightness—Capecitabine—esophageal cancer	0.0123	0.0123	CcSEcCtD
Iron—Rectal disorder—Capecitabine—esophageal cancer	0.0117	0.0117	CcSEcCtD
Iron—Anorectal disorder—Capecitabine—esophageal cancer	0.0109	0.0109	CcSEcCtD
Iron—Sneezing—Capecitabine—esophageal cancer	0.0104	0.0104	CcSEcCtD
Iron—Abscess—Cisplatin—esophageal cancer	0.00986	0.00986	CcSEcCtD
Iron—Infection—Carboplatin—esophageal cancer	0.00943	0.00943	CcSEcCtD
Iron—Tenderness—Cisplatin—esophageal cancer	0.00895	0.00895	CcSEcCtD
Iron—Extravasation—Cisplatin—esophageal cancer	0.00895	0.00895	CcSEcCtD
Iron—Cellulitis—Cisplatin—esophageal cancer	0.00858	0.00858	CcSEcCtD
Iron—Thrombosis—Capecitabine—esophageal cancer	0.00813	0.00813	CcSEcCtD
Iron—Pain—Carboplatin—esophageal cancer	0.00812	0.00812	CcSEcCtD
Iron—Hyperkalaemia—Cisplatin—esophageal cancer	0.00767	0.00767	CcSEcCtD
Iron—Wheezing—Cisplatin—esophageal cancer	0.00758	0.00758	CcSEcCtD
Iron—Body temperature increased—Carboplatin—esophageal cancer	0.0075	0.0075	CcSEcCtD
Iron—Fluid retention—Cisplatin—esophageal cancer	0.00741	0.00741	CcSEcCtD
Iron—Injection site pain—Capecitabine—esophageal cancer	0.00705	0.00705	CcSEcCtD
Iron—Rigors—Capecitabine—esophageal cancer	0.00705	0.00705	CcSEcCtD
Iron—Phlebitis—Cisplatin—esophageal cancer	0.00658	0.00658	CcSEcCtD
Iron—Chest discomfort—Capecitabine—esophageal cancer	0.0065	0.0065	CcSEcCtD
Iron—Skin discolouration—Capecitabine—esophageal cancer	0.00637	0.00637	CcSEcCtD
Iron—Deafness—Cisplatin—esophageal cancer	0.00633	0.00633	CcSEcCtD
Iron—Cellulitis—Capecitabine—esophageal cancer	0.00633	0.00633	CcSEcCtD
Iron—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00625	0.00625	CcSEcCtD
Iron—Lacrimation increased—Capecitabine—esophageal cancer	0.00624	0.00624	CcSEcCtD
Iron—Nasal congestion—Cisplatin—esophageal cancer	0.00622	0.00622	CcSEcCtD
Iron—Cyanosis—Methotrexate—esophageal cancer	0.00605	0.00605	CcSEcCtD
Iron—Inflammation—Capecitabine—esophageal cancer	0.00593	0.00593	CcSEcCtD
Iron—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00585	0.00585	CcSEcCtD
Iron—Injection site reaction—Capecitabine—esophageal cancer	0.00572	0.00572	CcSEcCtD
Iron—Melaena—Capecitabine—esophageal cancer	0.00562	0.00562	CcSEcCtD
Iron—Fluid retention—Capecitabine—esophageal cancer	0.00546	0.00546	CcSEcCtD
Iron—Abscess—Methotrexate—esophageal cancer	0.00541	0.00541	CcSEcCtD
Iron—Hypokalaemia—Cisplatin—esophageal cancer	0.00516	0.00516	CcSEcCtD
Iron—Cramp muscle—Cisplatin—esophageal cancer	0.0051	0.0051	CcSEcCtD
Iron—Nasopharyngitis—Cisplatin—esophageal cancer	0.00507	0.00507	CcSEcCtD
Iron—Sepsis—Capecitabine—esophageal cancer	0.00499	0.00499	CcSEcCtD
Iron—Extravasation—Methotrexate—esophageal cancer	0.00491	0.00491	CcSEcCtD
Iron—Ear pain—Capecitabine—esophageal cancer	0.00489	0.00489	CcSEcCtD
Iron—Phlebitis—Capecitabine—esophageal cancer	0.00485	0.00485	CcSEcCtD
Iron—Sweating increased—Cisplatin—esophageal cancer	0.00477	0.00477	CcSEcCtD
Iron—Skin discolouration—Methotrexate—esophageal cancer	0.00474	0.00474	CcSEcCtD
Iron—Swelling—Capecitabine—esophageal cancer	0.00473	0.00473	CcSEcCtD
Iron—Deafness—Capecitabine—esophageal cancer	0.00467	0.00467	CcSEcCtD
Iron—Vascular purpura—Capecitabine—esophageal cancer	0.00467	0.00467	CcSEcCtD
Iron—Hot flush—Capecitabine—esophageal cancer	0.00446	0.00446	CcSEcCtD
Iron—Menopausal symptoms—Capecitabine—esophageal cancer	0.00443	0.00443	CcSEcCtD
Iron—Inflammation—Methotrexate—esophageal cancer	0.00442	0.00442	CcSEcCtD
Iron—Purpura—Capecitabine—esophageal cancer	0.00433	0.00433	CcSEcCtD
Iron—Acute coronary syndrome—Cisplatin—esophageal cancer	0.0043	0.0043	CcSEcCtD
Iron—Arthritis—Capecitabine—esophageal cancer	0.0043	0.0043	CcSEcCtD
Iron—Myocardial infarction—Cisplatin—esophageal cancer	0.00428	0.00428	CcSEcCtD
Iron—Conjunctivitis—Cisplatin—esophageal cancer	0.00424	0.00424	CcSEcCtD
Iron—Melaena—Methotrexate—esophageal cancer	0.00418	0.00418	CcSEcCtD
Iron—Pain in extremity—Capecitabine—esophageal cancer	0.00418	0.00418	CcSEcCtD
Iron—Diplopia—Capecitabine—esophageal cancer	0.00418	0.00418	CcSEcCtD
Iron—Bradycardia—Cisplatin—esophageal cancer	0.00399	0.00399	CcSEcCtD
Iron—Cardiac arrest—Capecitabine—esophageal cancer	0.00397	0.00397	CcSEcCtD
Iron—Pulmonary oedema—Methotrexate—esophageal cancer	0.00381	0.00381	CcSEcCtD
Iron—Hypokalaemia—Capecitabine—esophageal cancer	0.0038	0.0038	CcSEcCtD
Iron—Nasopharyngitis—Capecitabine—esophageal cancer	0.00373	0.00373	CcSEcCtD
Iron—Sepsis—Methotrexate—esophageal cancer	0.00372	0.00372	CcSEcCtD
Iron—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00368	0.00368	CcSEcCtD
Iron—Eye disorder—Cisplatin—esophageal cancer	0.00366	0.00366	CcSEcCtD
Iron—Lymphadenopathy—Methotrexate—esophageal cancer	0.00364	0.00364	CcSEcCtD
Iron—Flushing—Cisplatin—esophageal cancer	0.00364	0.00364	CcSEcCtD
Iron—Bronchospasm—Capecitabine—esophageal cancer	0.00355	0.00355	CcSEcCtD
Iron—Mediastinal disorder—Cisplatin—esophageal cancer	0.00353	0.00353	CcSEcCtD
Iron—Sweating increased—Capecitabine—esophageal cancer	0.00352	0.00352	CcSEcCtD
Iron—Angina pectoris—Capecitabine—esophageal cancer	0.00352	0.00352	CcSEcCtD
Iron—Arrhythmia—Cisplatin—esophageal cancer	0.0035	0.0035	CcSEcCtD
Iron—Erythema—Cisplatin—esophageal cancer	0.00341	0.00341	CcSEcCtD
Iron—Malnutrition—Cisplatin—esophageal cancer	0.00341	0.00341	CcSEcCtD
Iron—Flatulence—Cisplatin—esophageal cancer	0.00336	0.00336	CcSEcCtD
Iron—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00335	0.00335	CcSEcCtD
Iron—Muscle spasms—Cisplatin—esophageal cancer	0.00328	0.00328	CcSEcCtD
Iron—Hyperglycaemia—Capecitabine—esophageal cancer	0.00326	0.00326	CcSEcCtD
Iron—Pneumonia—Capecitabine—esophageal cancer	0.00324	0.00324	CcSEcCtD
Iron—Infestation NOS—Capecitabine—esophageal cancer	0.00322	0.00322	CcSEcCtD
Iron—Infestation—Capecitabine—esophageal cancer	0.00322	0.00322	CcSEcCtD
Iron—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00321	0.00321	CcSEcCtD
Iron—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00317	0.00317	CcSEcCtD
Iron—Ill-defined disorder—Cisplatin—esophageal cancer	0.00317	0.00317	CcSEcCtD
Iron—Myocardial infarction—Capecitabine—esophageal cancer	0.00315	0.00315	CcSEcCtD
Iron—Anaemia—Cisplatin—esophageal cancer	0.00315	0.00315	CcSEcCtD
Iron—Urinary tract infection—Capecitabine—esophageal cancer	0.00313	0.00313	CcSEcCtD
Iron—Conjunctivitis—Capecitabine—esophageal cancer	0.00313	0.00313	CcSEcCtD
Iron—Malaise—Cisplatin—esophageal cancer	0.00308	0.00308	CcSEcCtD
Iron—Haematuria—Capecitabine—esophageal cancer	0.00307	0.00307	CcSEcCtD
Iron—Convulsion—Cisplatin—esophageal cancer	0.00296	0.00296	CcSEcCtD
Iron—Bradycardia—Capecitabine—esophageal cancer	0.00294	0.00294	CcSEcCtD
Iron—Myalgia—Cisplatin—esophageal cancer	0.0029	0.0029	CcSEcCtD
Iron—Haemoglobin—Capecitabine—esophageal cancer	0.0029	0.0029	CcSEcCtD
Iron—Rhinitis—Capecitabine—esophageal cancer	0.0029	0.0029	CcSEcCtD
Iron—Haemorrhage—Capecitabine—esophageal cancer	0.00289	0.00289	CcSEcCtD
Iron—Hypoaesthesia—Capecitabine—esophageal cancer	0.00287	0.00287	CcSEcCtD
Iron—Discomfort—Cisplatin—esophageal cancer	0.00287	0.00287	CcSEcCtD
Iron—Pharyngitis—Capecitabine—esophageal cancer	0.00287	0.00287	CcSEcCtD
Iron—Oedema peripheral—Capecitabine—esophageal cancer	0.00285	0.00285	CcSEcCtD
Iron—Anaphylactic shock—Cisplatin—esophageal cancer	0.00278	0.00278	CcSEcCtD
Iron—Oedema—Cisplatin—esophageal cancer	0.00278	0.00278	CcSEcCtD
Iron—Infection—Cisplatin—esophageal cancer	0.00277	0.00277	CcSEcCtD
Iron—Nervous system disorder—Cisplatin—esophageal cancer	0.00273	0.00273	CcSEcCtD
Iron—Tachycardia—Cisplatin—esophageal cancer	0.00272	0.00272	CcSEcCtD
Iron—Eye disorder—Capecitabine—esophageal cancer	0.0027	0.0027	CcSEcCtD
Iron—Hyperhidrosis—Cisplatin—esophageal cancer	0.00269	0.00269	CcSEcCtD
Iron—Flushing—Capecitabine—esophageal cancer	0.00268	0.00268	CcSEcCtD
Iron—Anorexia—Cisplatin—esophageal cancer	0.00265	0.00265	CcSEcCtD
Iron—Angiopathy—Capecitabine—esophageal cancer	0.00262	0.00262	CcSEcCtD
Iron—Mediastinal disorder—Capecitabine—esophageal cancer	0.0026	0.0026	CcSEcCtD
Iron—Hypotension—Cisplatin—esophageal cancer	0.0026	0.0026	CcSEcCtD
Iron—Chills—Capecitabine—esophageal cancer	0.00259	0.00259	CcSEcCtD
Iron—Arrhythmia—Capecitabine—esophageal cancer	0.00258	0.00258	CcSEcCtD
Iron—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00254	0.00254	CcSEcCtD
Iron—Malnutrition—Capecitabine—esophageal cancer	0.00251	0.00251	CcSEcCtD
Iron—Erythema—Capecitabine—esophageal cancer	0.00251	0.00251	CcSEcCtD
Iron—Paraesthesia—Cisplatin—esophageal cancer	0.0025	0.0025	CcSEcCtD
Iron—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.0025	0.0025	CcSEcCtD
Iron—Dyspnoea—Cisplatin—esophageal cancer	0.00248	0.00248	CcSEcCtD
Iron—Flatulence—Capecitabine—esophageal cancer	0.00248	0.00248	CcSEcCtD
Iron—Dysgeusia—Capecitabine—esophageal cancer	0.00246	0.00246	CcSEcCtD
Iron—Back pain—Capecitabine—esophageal cancer	0.00243	0.00243	CcSEcCtD
Iron—Decreased appetite—Cisplatin—esophageal cancer	0.00242	0.00242	CcSEcCtD
Iron—Muscle spasms—Capecitabine—esophageal cancer	0.00242	0.00242	CcSEcCtD
Iron—Pneumonia—Methotrexate—esophageal cancer	0.00241	0.00241	CcSEcCtD
Iron—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.0024	0.0024	CcSEcCtD
Iron—Infestation—Methotrexate—esophageal cancer	0.0024	0.0024	CcSEcCtD
Iron—Infestation NOS—Methotrexate—esophageal cancer	0.0024	0.0024	CcSEcCtD
Iron—Pain—Cisplatin—esophageal cancer	0.00238	0.00238	CcSEcCtD
Iron—Ill-defined disorder—Capecitabine—esophageal cancer	0.00233	0.00233	CcSEcCtD
Iron—Conjunctivitis—Methotrexate—esophageal cancer	0.00233	0.00233	CcSEcCtD
Iron—Anaemia—Capecitabine—esophageal cancer	0.00232	0.00232	CcSEcCtD
Iron—Sweating—Methotrexate—esophageal cancer	0.0023	0.0023	CcSEcCtD
Iron—Feeling abnormal—Cisplatin—esophageal cancer	0.00229	0.00229	CcSEcCtD
Iron—Haematuria—Methotrexate—esophageal cancer	0.00228	0.00228	CcSEcCtD
Iron—Malaise—Capecitabine—esophageal cancer	0.00227	0.00227	CcSEcCtD
Iron—Syncope—Capecitabine—esophageal cancer	0.00226	0.00226	CcSEcCtD
Iron—Loss of consciousness—Capecitabine—esophageal cancer	0.00221	0.00221	CcSEcCtD
Iron—Body temperature increased—Cisplatin—esophageal cancer	0.0022	0.0022	CcSEcCtD
Iron—Cough—Capecitabine—esophageal cancer	0.00219	0.00219	CcSEcCtD
Iron—Hypertension—Capecitabine—esophageal cancer	0.00217	0.00217	CcSEcCtD
Iron—Haemoglobin—Methotrexate—esophageal cancer	0.00216	0.00216	CcSEcCtD
Iron—Haemorrhage—Methotrexate—esophageal cancer	0.00215	0.00215	CcSEcCtD
Iron—Chest pain—Capecitabine—esophageal cancer	0.00214	0.00214	CcSEcCtD
Iron—Myalgia—Capecitabine—esophageal cancer	0.00214	0.00214	CcSEcCtD
Iron—Arthralgia—Capecitabine—esophageal cancer	0.00214	0.00214	CcSEcCtD
Iron—Pharyngitis—Methotrexate—esophageal cancer	0.00213	0.00213	CcSEcCtD
Iron—Discomfort—Capecitabine—esophageal cancer	0.00212	0.00212	CcSEcCtD
Iron—Dry mouth—Capecitabine—esophageal cancer	0.00209	0.00209	CcSEcCtD
Iron—Confusional state—Capecitabine—esophageal cancer	0.00207	0.00207	CcSEcCtD
Iron—Oedema—Capecitabine—esophageal cancer	0.00205	0.00205	CcSEcCtD
Iron—Hypersensitivity—Cisplatin—esophageal cancer	0.00205	0.00205	CcSEcCtD
Iron—Infection—Capecitabine—esophageal cancer	0.00204	0.00204	CcSEcCtD
Iron—Shock—Capecitabine—esophageal cancer	0.00202	0.00202	CcSEcCtD
Iron—Nervous system disorder—Capecitabine—esophageal cancer	0.00201	0.00201	CcSEcCtD
Iron—Eye disorder—Methotrexate—esophageal cancer	0.00201	0.00201	CcSEcCtD
Iron—Tachycardia—Capecitabine—esophageal cancer	0.002	0.002	CcSEcCtD
Iron—Asthenia—Cisplatin—esophageal cancer	0.002	0.002	CcSEcCtD
Iron—Hyperhidrosis—Capecitabine—esophageal cancer	0.00198	0.00198	CcSEcCtD
Iron—Anorexia—Capecitabine—esophageal cancer	0.00196	0.00196	CcSEcCtD
Iron—Angiopathy—Methotrexate—esophageal cancer	0.00195	0.00195	CcSEcCtD
Iron—Mediastinal disorder—Methotrexate—esophageal cancer	0.00194	0.00194	CcSEcCtD
Iron—Chills—Methotrexate—esophageal cancer	0.00193	0.00193	CcSEcCtD
Iron—Hypotension—Capecitabine—esophageal cancer	0.00192	0.00192	CcSEcCtD
Iron—Diarrhoea—Cisplatin—esophageal cancer	0.00191	0.00191	CcSEcCtD
Iron—Erythema—Methotrexate—esophageal cancer	0.00187	0.00187	CcSEcCtD
Iron—Malnutrition—Methotrexate—esophageal cancer	0.00187	0.00187	CcSEcCtD
Iron—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00187	0.00187	CcSEcCtD
Iron—Paraesthesia—Capecitabine—esophageal cancer	0.00184	0.00184	CcSEcCtD
Iron—Dysgeusia—Methotrexate—esophageal cancer	0.00183	0.00183	CcSEcCtD
Iron—Dyspnoea—Capecitabine—esophageal cancer	0.00183	0.00183	CcSEcCtD
Iron—Back pain—Methotrexate—esophageal cancer	0.00181	0.00181	CcSEcCtD
Iron—Dyspepsia—Capecitabine—esophageal cancer	0.00181	0.00181	CcSEcCtD
Iron—Decreased appetite—Capecitabine—esophageal cancer	0.00178	0.00178	CcSEcCtD
Iron—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00177	0.00177	CcSEcCtD
Iron—Vomiting—Cisplatin—esophageal cancer	0.00177	0.00177	CcSEcCtD
Iron—Fatigue—Capecitabine—esophageal cancer	0.00177	0.00177	CcSEcCtD
Iron—Rash—Cisplatin—esophageal cancer	0.00176	0.00176	CcSEcCtD
Iron—Pain—Capecitabine—esophageal cancer	0.00176	0.00176	CcSEcCtD
Iron—Constipation—Capecitabine—esophageal cancer	0.00176	0.00176	CcSEcCtD
Iron—Dermatitis—Cisplatin—esophageal cancer	0.00175	0.00175	CcSEcCtD
Iron—Ill-defined disorder—Methotrexate—esophageal cancer	0.00174	0.00174	CcSEcCtD
Iron—Anaemia—Methotrexate—esophageal cancer	0.00173	0.00173	CcSEcCtD
Iron—Feeling abnormal—Capecitabine—esophageal cancer	0.00169	0.00169	CcSEcCtD
Iron—Malaise—Methotrexate—esophageal cancer	0.00169	0.00169	CcSEcCtD
Iron—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00168	0.00168	CcSEcCtD
Iron—Nausea—Cisplatin—esophageal cancer	0.00165	0.00165	CcSEcCtD
Iron—Cough—Methotrexate—esophageal cancer	0.00163	0.00163	CcSEcCtD
Iron—Urticaria—Capecitabine—esophageal cancer	0.00163	0.00163	CcSEcCtD
Iron—Abdominal pain—Capecitabine—esophageal cancer	0.00162	0.00162	CcSEcCtD
Iron—Body temperature increased—Capecitabine—esophageal cancer	0.00162	0.00162	CcSEcCtD
Iron—Convulsion—Methotrexate—esophageal cancer	0.00162	0.00162	CcSEcCtD
Iron—Chest pain—Methotrexate—esophageal cancer	0.00159	0.00159	CcSEcCtD
Iron—Myalgia—Methotrexate—esophageal cancer	0.00159	0.00159	CcSEcCtD
Iron—Arthralgia—Methotrexate—esophageal cancer	0.00159	0.00159	CcSEcCtD
Iron—Discomfort—Methotrexate—esophageal cancer	0.00157	0.00157	CcSEcCtD
Iron—Confusional state—Methotrexate—esophageal cancer	0.00154	0.00154	CcSEcCtD
Iron—Anaphylactic shock—Methotrexate—esophageal cancer	0.00153	0.00153	CcSEcCtD
Iron—Infection—Methotrexate—esophageal cancer	0.00152	0.00152	CcSEcCtD
Iron—Hypersensitivity—Capecitabine—esophageal cancer	0.00151	0.00151	CcSEcCtD
Iron—Nervous system disorder—Methotrexate—esophageal cancer	0.0015	0.0015	CcSEcCtD
Iron—Hyperhidrosis—Methotrexate—esophageal cancer	0.00148	0.00148	CcSEcCtD
Iron—Asthenia—Capecitabine—esophageal cancer	0.00147	0.00147	CcSEcCtD
Iron—Anorexia—Methotrexate—esophageal cancer	0.00146	0.00146	CcSEcCtD
Iron—Pruritus—Capecitabine—esophageal cancer	0.00145	0.00145	CcSEcCtD
Iron—Hypotension—Methotrexate—esophageal cancer	0.00143	0.00143	CcSEcCtD
Iron—Diarrhoea—Capecitabine—esophageal cancer	0.0014	0.0014	CcSEcCtD
Iron—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00139	0.00139	CcSEcCtD
Iron—Paraesthesia—Methotrexate—esophageal cancer	0.00137	0.00137	CcSEcCtD
Iron—Dyspnoea—Methotrexate—esophageal cancer	0.00136	0.00136	CcSEcCtD
Iron—Somnolence—Methotrexate—esophageal cancer	0.00136	0.00136	CcSEcCtD
Iron—Dizziness—Capecitabine—esophageal cancer	0.00136	0.00136	CcSEcCtD
Iron—Dyspepsia—Methotrexate—esophageal cancer	0.00135	0.00135	CcSEcCtD
Iron—Decreased appetite—Methotrexate—esophageal cancer	0.00133	0.00133	CcSEcCtD
Iron—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00132	0.00132	CcSEcCtD
Iron—Fatigue—Methotrexate—esophageal cancer	0.00132	0.00132	CcSEcCtD
Iron—Pain—Methotrexate—esophageal cancer	0.00131	0.00131	CcSEcCtD
Iron—Vomiting—Capecitabine—esophageal cancer	0.00131	0.00131	CcSEcCtD
Iron—Rash—Capecitabine—esophageal cancer	0.00129	0.00129	CcSEcCtD
Iron—Dermatitis—Capecitabine—esophageal cancer	0.00129	0.00129	CcSEcCtD
Iron—Headache—Capecitabine—esophageal cancer	0.00129	0.00129	CcSEcCtD
Iron—Feeling abnormal—Methotrexate—esophageal cancer	0.00126	0.00126	CcSEcCtD
Iron—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00125	0.00125	CcSEcCtD
Iron—Nausea—Capecitabine—esophageal cancer	0.00122	0.00122	CcSEcCtD
Iron—Urticaria—Methotrexate—esophageal cancer	0.00121	0.00121	CcSEcCtD
Iron—Abdominal pain—Methotrexate—esophageal cancer	0.00121	0.00121	CcSEcCtD
Iron—Body temperature increased—Methotrexate—esophageal cancer	0.00121	0.00121	CcSEcCtD
Iron—Hypersensitivity—Methotrexate—esophageal cancer	0.00113	0.00113	CcSEcCtD
Iron—Asthenia—Methotrexate—esophageal cancer	0.0011	0.0011	CcSEcCtD
Iron—Pruritus—Methotrexate—esophageal cancer	0.00108	0.00108	CcSEcCtD
Iron—Diarrhoea—Methotrexate—esophageal cancer	0.00105	0.00105	CcSEcCtD
Iron—Dizziness—Methotrexate—esophageal cancer	0.00101	0.00101	CcSEcCtD
Iron—Vomiting—Methotrexate—esophageal cancer	0.000972	0.000972	CcSEcCtD
Iron—Rash—Methotrexate—esophageal cancer	0.000963	0.000963	CcSEcCtD
Iron—Dermatitis—Methotrexate—esophageal cancer	0.000963	0.000963	CcSEcCtD
Iron—Headache—Methotrexate—esophageal cancer	0.000957	0.000957	CcSEcCtD
Iron—Nausea—Methotrexate—esophageal cancer	0.000908	0.000908	CcSEcCtD
